Related references
Note: Only part of the references are listed.Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways
Jacob I. Ayers et al.
ACTA NEUROPATHOLOGICA (2016)
Intraspinal Stem Cell Transplantation for Amyotrophic Lateral Sclerosis
Kevin S. Chen et al.
ANNALS OF NEUROLOGY (2016)
Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis
Diane Moujalled et al.
CNS DRUGS (2016)
A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression
Michael D. Weiss et al.
NEUROLOGY (2016)
Developing drug strategies for the neuroprotective treatment of acute ischemic stroke
Antonino Tuttolomondo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Acute Stroke Intervention A Systematic Review
Shyam Prabhakaran et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study (vol 14, pg 478, 2015)
P. Menon et al.
LANCET NEUROLOGY (2015)
The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation
Xinxiu Liu et al.
NEUROGENETICS (2015)
Edaravone, a Free Radical Scavenger, Delayed Symptomatic and Pathological Progression of Motor Neuron Disease in the Wobbler Mouse
Ken Ikeda et al.
PLOS ONE (2015)
A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial
Kazumoto Shibuya et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2015)
Developing drug strategies for the neuroprotective treatment of acute ischemic stroke
Antonino Tuttolomondo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Axonal Ion Channel Dysfunction in C9orf72 Familial Amyotrophic Lateral Sclerosis
Nimeshan Geevasinga et al.
JAMA NEUROLOGY (2015)
Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial
Susanna B. Park et al.
EBIOMEDICINE (2015)
Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study
Parvathi Menon et al.
LANCET NEUROLOGY (2015)
Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis
John Ravits
EXPERIMENTAL NEUROLOGY (2014)
Spreading of amyotrophic lateral sclerosis lesions-multifocal hits and local propagation?
Teruhiko Sekiguchi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor Neurons
Brian J. Wainger et al.
CELL REPORTS (2014)
Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
Koji Abe et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Amyotrophic Lateral Sclerosis - Cell Based Therapy and Novel Therapeutic Development
Changsung Kim et al.
Experimental Neurobiology (2014)
Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons
Sandra Almeida et al.
ACTA NEUROPATHOLOGICA (2013)
Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis
Steve Vucic et al.
BRAIN (2013)
Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights
Steve Vucic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit E. Cudkowicz et al.
LANCET NEUROLOGY (2013)
Motoneuron Differentiation of Induced Pluripotent Stem Cells from SOD1G93A Mice
Xiao-Li Yao et al.
PLOS ONE (2013)
Does interneuronal dysfunction contribute to neurodegeneration in amyotrophic lateral sclerosis?
Martin R. Turner et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis
Benjamin C. Cheah et al.
CLINICAL NEUROPHYSIOLOGY (2012)
Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis
Kazuaki Kanai et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability
Bilada Bilican et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells
Naohiro Egawa et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Robert G. Miller et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Integration of structural and functional magnetic resonance imaging in amyotrophic lateral sclerosis
Gwenaelle Douaud et al.
BRAIN (2011)
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
Etienne Aliot et al.
EUROPACE (2011)
Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study
Kazumoto Shibuya et al.
EXPERIMENTAL NEUROLOGY (2011)
Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients
Miguel Mitne-Neto et al.
HUMAN MOLECULAR GENETICS (2011)
Distal motor axonal dysfunction in amyotrophic lateral sclerosis
Yu-ichi Noto et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Increased expression of the beta3 subunit of voltage-gated Na plus channels in the spinal cord of the SOD1G93A mouse
Michele Nutini et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
B. C. Cheah et al.
CURRENT MEDICINAL CHEMISTRY (2010)
AMPA receptor-mediated neuronal death in sporadic ALS
Shin Kwak et al.
NEUROPATHOLOGY (2010)
Neural KCNQ (Kv7) channels
David A. Brown et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Progressive Changes in Synaptic Inputs to Motoneurons in Adult Sacral Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis
Mingchen Jiang et al.
JOURNAL OF NEUROSCIENCE (2009)
Accumulation of oxidative stress around the stroke-like lesions of MELAS patients
Yuri Katayama et al.
MITOCHONDRION (2009)
Axonal ion channels from bench to bedside: A translational neuroscience perspective
Arun V. Krishnan et al.
PROGRESS IN NEUROBIOLOGY (2009)
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: An (C-11)-flumazenil PET study
Paul Wicks et al.
AMYOTROPHIC LATERAL SCLEROSIS (2008)
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Steve Vucic et al.
BRAIN (2008)
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro
Nerijus Lamanauskas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells
Ya-Jean Wang et al.
LIFE SCIENCES (2008)
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons
John T. Dimos et al.
SCIENCE (2008)
D-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Jumpei Sasabe et al.
EMBO JOURNAL (2007)
Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures
R. J. Porter et al.
NEUROLOGY (2007)
Transcallosal inhibition in amyotrophic lateral sclerosis
M. Wittstock et al.
CLINICAL NEUROPHYSIOLOGY (2007)
GABAA-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients
Susanne Petri et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease
Steve Vucic et al.
BRAIN (2006)
Axonal excitability properties in amyotrophic lateral sclerosis
Steve Vucic et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Distal excitability changes in motor axons in amyotrophic lateral sclerosis
Miho Nakata et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Differential expression of GABAA and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons:: possible implications for selective vulnerability of mononeurons
Louis-Etienne Lorenzo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study
Benjamin Stephens et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Assessment of cortical excitability using threshold tracking techniques
S Vucic et al.
MUSCLE & NERVE (2006)
Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage
K Kanai et al.
BRAIN (2006)
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS
MR Turner et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Manganese porphyrin given at symptom onset markedly extends survival of ALS mice
JP Crow et al.
ANNALS OF NEUROLOGY (2005)
General mechanisms of axonal damage and its prevention
PK Stys
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Distinct cerebral lesions in sporadic and 'D90A' SOD1 ALS:: studies with [11C]flumazenil PET
MR Turner et al.
BRAIN (2005)
The Neurophysiological Index in ALS
M Swash et al.
AMYOTROPHIC LATERAL SCLEROSIS (2004)
Cortical selective vulnerability in motor neuron disease: a morphometric study
S Maekawa et al.
BRAIN (2004)
Distribution of GABAA receptor mRNA in the motor cortex of ALS patients
S Petri et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Mechanisms, challenges and opportunities in stroke
EH Lo et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis
G Zanette et al.
JOURNAL OF NEUROLOGY (2002)
Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis
G Zanette et al.
CLINICAL NEUROPHYSIOLOGY (2002)
Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis
PR Heath et al.
MUSCLE & NERVE (2002)
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis
G Bensimon et al.
JOURNAL OF NEUROLOGY (2002)
Extramotor involvement in ALS:: PET studies with the GABAA ligand [11C]flumazenil
CM Lloyd et al.
BRAIN (2000)
Riluzole inhibits the persistent sodium current in mammalian CNS neurons
A Urbani et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
